A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders-Reference-Cited by-同舟云学术

A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders

Published:2014-09-18 Issue:1 Volume:1327 Page:112-130
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Gastfriend David R.¹

Affiliation:

1. Treatment Research Institute Philadelphia Pennsylvania

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.12538

Reference95 articles.

1. Measuring the Global Burden of Disease

2. Economic Costs of Excessive Alcohol Consumption in the U.S., 2006

3. Office of the National Drug Control Policy (ONDCP).2013.National drug control strategy.http://www.whitehouse.gov//sites/default/files/ondcp/policy‐and‐research3/ndcs_2013.pdf. Accessed on August 14 2013.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department;Academic Emergency Medicine;2024-05

2. Systems-level biomarkers identification and drug repositioning in colorectal cancer;World Journal of Gastrointestinal Oncology;2021-07-15

3. Systems-level biomarkers identification and drug repositioning in colorectal cancer;World Journal of Gastrointestinal Oncology;2021-07-15

4. Alcohol and Human Health: What Is the Evidence?;Annual Review of Food Science and Technology;2020-03-25

5. Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA;Neurotherapeutics;2020-01